000 | 01980 a2200577 4500 | ||
---|---|---|---|
005 | 20250517031554.0 | ||
264 | 0 | _c20160223 | |
008 | 201602s 0 0 eng d | ||
022 | _a1872-6968 | ||
024 | 7 |
_a10.1016/j.clineuro.2015.01.006 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEning, Genevieve | |
245 | 0 | 0 |
_aRisk factors for glioblastoma therapy associated complications. _h[electronic resource] |
260 |
_bClinical neurology and neurosurgery _cJul 2015 |
||
300 |
_a55-9 p. _bdigital |
||
500 | _aPublication Type: Clinical Study; Journal Article | ||
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 |
_aBrain Neoplasms _xmortality |
650 | 0 | 4 |
_aChemoradiotherapy, Adjuvant _xadverse effects |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 |
_aDacarbazine _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlioblastoma _xmortality |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntracranial Hemorrhages _xepidemiology |
650 | 0 | 4 | _aKaplan-Meier Estimate |
650 | 0 | 4 | _aKarnofsky Performance Status |
650 | 0 | 4 | _aLogistic Models |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMotor Disorders _xepidemiology |
650 | 0 | 4 | _aMultivariate Analysis |
650 | 0 | 4 | _aNeurosurgical Procedures |
650 | 0 | 4 | _aOdds Ratio |
650 | 0 | 4 |
_aPostoperative Complications _xepidemiology |
650 | 0 | 4 |
_aPostoperative Hemorrhage _xepidemiology |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aPsychotic Disorders _xepidemiology |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aSeizures _xepidemiology |
650 | 0 | 4 |
_aSurgical Wound Infection _xepidemiology |
650 | 0 | 4 | _aTemozolomide |
700 | 1 | _aOsterheld, Fransiska | |
700 | 1 | _aCapper, David | |
700 | 1 | _aSchmieder, Kirsten | |
700 | 1 | _aBrenke, Christopher | |
773 | 0 |
_tClinical neurology and neurosurgery _gvol. 134 _gp. 55-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clineuro.2015.01.006 _zAvailable from publisher's website |
999 |
_c24870004 _d24870004 |